An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol

BACKGROUND: Gonorrhoea is an ongoing public health concern due to its rising incidence and the emergence of antibiotic resistance. There are an estimated 82 million new Neisseria gonorrhoeae infections each year, with several populations at higher risk for gonococcal infection, including gay and bis...

Descripción completa

Detalles Bibliográficos
Autores principales: Thng, Caroline, Semchenko, Evgeny A., Hughes, Ian, O’Sullivan, Maree, Seib, Kate L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062254/
https://www.ncbi.nlm.nih.gov/pubmed/36997957
http://dx.doi.org/10.1186/s12889-023-15516-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062254/
https://www.ncbi.nlm.nih.gov/pubmed/36997957
http://dx.doi.org/10.1186/s12889-023-15516-y

Ejemplares similares